Detailed Information

Cited 0 time in webofscience Cited 0 time in scopus
Metadata Downloads

히드록시프로필메칠셀룰로오스 프탈레이트 및 에칠셀룰로오스를 이용한 이부딜라스트 함유서방성 매트릭스 정제의 개발

Full metadata record
DC Field Value Language
dc.contributor.author오동훈-
dc.contributor.author이종달-
dc.contributor.author유동성-
dc.contributor.author장기영-
dc.contributor.author임종섭-
dc.contributor.author성정훈-
dc.contributor.author한묘정-
dc.contributor.author권태협-
dc.contributor.author양호준-
dc.contributor.author박병철-
dc.contributor.author이종숙-
dc.contributor.author용철순-
dc.contributor.author최한곤-
dc.date.accessioned2021-06-23T20:05:19Z-
dc.date.available2021-06-23T20:05:19Z-
dc.date.created2021-02-01-
dc.date.issued2007-12-
dc.identifier.issn2093-5552-
dc.identifier.urihttps://scholarworks.bwise.kr/erica/handle/2021.sw.erica/43932-
dc.description.abstractTo develop a sustained-release tablet which had the similar dissolution to commercial ibudilast-loaded sustained-release capsule, the tablets were prepared using hydroxypropylmethylcellulose phthalate (HPMCP), ethylcellulose (EC) and hydroxypropylcellulose (HPC), and dissolution test were carried out with paddle method in KP. The tablet prepared only with HPMCP and EC showed sno similar dissolution pattern to the commercial product. As the ratio of HPMCP/HPC in tablet decreased, the dissolution rate of drug decreased in pH 1.2 but increased in pH 6.8. Furthermore, an ibudilast-loaded sustained-release tablet composed of [ibudilast/EC/HPMCP/HPC (10/10/170/10 mg/tab)] gave similar dissolution to commercial product in pH 1.2 for 3 h and in pH 6.8 for 10 h. Thus, it could be a potential candidate for the substitute of commercial capsule.-
dc.language한국어-
dc.language.isoko-
dc.publisher한국약제학회-
dc.title히드록시프로필메칠셀룰로오스 프탈레이트 및 에칠셀룰로오스를 이용한 이부딜라스트 함유서방성 매트릭스 정제의 개발-
dc.title.alternativeFormulation of Sustained Release Matrix Tablets Containing Ibudilastwith Hydroxypropylmethylcellulose Phthalate and Ethylcellulose-
dc.typeArticle-
dc.contributor.affiliatedAuthor최한곤-
dc.identifier.doi10.4333/KPS.2007.37.6.355-
dc.identifier.bibliographicCitationJournal of Pharmaceutical Investigation, v.37, no.6, pp.355 - 358-
dc.relation.isPartOfJournal of Pharmaceutical Investigation-
dc.citation.titleJournal of Pharmaceutical Investigation-
dc.citation.volume37-
dc.citation.number6-
dc.citation.startPage355-
dc.citation.endPage358-
dc.type.rimsART-
dc.identifier.kciidART001208827-
dc.description.journalClass2-
dc.description.isOpenAccessN-
dc.description.journalRegisteredClasskci-
dc.subject.keywordAuthorIbudilast-
dc.subject.keywordAuthorSustained release tablet-
dc.subject.keywordAuthorDissolution-
dc.subject.keywordAuthorHPMCP-
dc.subject.keywordAuthorEC-
dc.subject.keywordAuthorHPC-
dc.identifier.urlhttps://www.koreascience.or.kr/article/JAKO200706414521080.page-
Files in This Item
Go to Link
Appears in
Collections
COLLEGE OF PHARMACY > DEPARTMENT OF PHARMACY > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Researcher Choi, Han Gon photo

Choi, Han Gon
COLLEGE OF PHARMACY (DEPARTMENT OF PHARMACY)
Read more

Altmetrics

Total Views & Downloads

BROWSE